Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Passage BIO, Inc. | 58,000 | reported | 16 Mar 2026 | tx 9+2,936,148−14,076 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 16 Mar 2026 | GRANT_AWARD | Passage BIO, Inc. | 58,000 | 0.00 USD | deriv |
| 08 Jan 2026 | EXERCISE | Passage BIO, Inc. | 10,000 | — | |
| 08 Jan 2026 | SALE | Passage BIO, Inc. | 4,076 | 18.44 USD | |
| 08 Jan 2026 | EXERCISE | Passage BIO, Inc. | 10,000 | 0.00 USD | deriv |
| 15 Jan 2025 | GRANT_AWARD | Passage BIO, Inc. | 20,000 | 0.00 USD | deriv |
| 15 Mar 2025 | GRANT_AWARD | Passage BIO, Inc. | 779,533 | 0.00 USD | deriv |
| 15 Mar 2024 | GRANT_AWARD | Passage BIO, Inc. | 575,000 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | Passage BIO, Inc. | 608,615 | 0.00 USD | deriv |
| 10 Oct 2022 | GRANT_AWARD | Passage BIO, Inc. | 885,000 | 0.00 USD | deriv |